Internal Medicine

Doç. Dr. Birol Ocak

Doctor and researcher S. B. Ü. Bursa Yüksek İhtisas Eğitim ve Araştırma Hastanesi Bursa
Breast NeoplasmsCarcinoma, Renal CellKidney NeoplasmsEndometrial Neoplasms
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source
  • Breast Neoplasms 4 publications
    Source: OpenAlex / PubMed MeSHView publications
  • Carcinoma, Renal Cell 2 publications
  • Kidney Neoplasms 2 publications
  • Endometrial Neoplasms 2 publications

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyInternal Medicinesaglik.gov.trFrom source
  • InstitutionS. B. Ü. Bursa Yüksek İhtisas Eğitim ve Araştırma Hastanesisaglik.gov.trFrom source
  • Area of workBreast NeoplasmsExtracted from 4 publications · Model version —From source
  • Publications72 publicationsORCID, OpenAlex, Europe PMCFrom source
  • ORCID0000-0001-7537-1699ORCIDFrom source
  • Last synchronised5 November 2026 10:36https://bursayuksekihtisaseah.saglik.gov.tr/TR-844163/doktorlarimiz.html#birol-ocaksaglik.gov.tr

Scientific work

Publications on Breast Neoplasms

72 publications

  1. Long-Term Survival of Cancer Patients Following COVID-19 Infection: Prognostic Value of Inflammatory Indices and Vaccination Status

    Uludağ Üniversitesi Tıp Fakültesi Dergisi, 2026

    DOI 10.32708/uutfd.1898579 Open-access full textSource: ORCID

  2. Predicting the Unpredictable: Prognostic Role of Systemic Inflammatory Indices and Tumor Biology of Neoadjuvant Chemotherapy Response in Gastric and Gastroesophageal Junction Cancer—Insights from a Systematic Review and Real-World Experience

    Journal of Clinical Medicine, 2026

    DOI 10.3390/jcm15041484 PMID 41753172 Open-access full textSource: ORCID

  3. Optimizing Patient Selection for Bevacizumab Plus Irinotecan in Recurrent High Grade Glioma: Superiority of the Neutrophil-to-Lymphocyte Ratio Over Other Systemic Inflammation Indices

    Eurasian Journal of Medical Investigation, 2026

    DOI 10.14744/ejmi.263037 Source: OpenAlex

  4. Prognostic Value of Albumin-to-CEA Ratio in Metastatic Colorectal Cancer: A Retrospective Study

    Biomedicines, 2026

    DOI 10.3390/biomedicines14030579 PMID 41898226 Open-access full textSource: Europe PMC

  5. Clinicopathological Factors Associated with Pathological Complete Response After Neoadjuvant Chemotherapy in Breast Cancer: A Single-Center Retrospective Study

    Journal of Bursa Faculty of Medicine, 2026

    DOI 10.61678/bursamed.2045961 Open-access full textSource: ORCID

  6. Beyond conventional staging: prognostic significance of systemic inflammatory indices at diagnosis in malignant peripheral nerve sheath tumors

    Turkish Journal of Clinics and Laboratory, 2026

    DOI 10.18663/tjcl.1860402 Open-access full textSource: ORCID

  7. Integrating Tumor Biology and Host Factors in mCRPC: The Prognostic Value of ‘Time to Castration Resistance’, Systemic Inflammation, and Comorbidity Burden in Patients Treated with Enzalutamide

    Diagnostics, 2026

    DOI 10.3390/diagnostics16060950 PMID 41897683 Open-access full textSource: ORCID

  8. Long-Term Oncological Outcomes for Locally Advanced Rectal Cancer Patients with Pathological Complete Response After Neoadjuvant Chemoradiotherapy: A Turkish Oncology Group Study

    Cancer Investigation, 2025

    DOI 10.1080/07357907.2025.2595536 PMID 41347635 1 citation (Europe PMC) Source: OpenAlex

  9. Primary neuroendocrine tumors of the breast according to the WHO 2019 classification; real life experiences of rare tumor types of the breast

    The Oncologist, 2025

    DOI 10.1093/oncolo/oyaf171 PMID 40588422 Open-access full textSource: ORCID

  10. Evaluation of complementary and alternative medicine use in cancer patients: A survey study in Turkey

    Advances in Integrative Medicine, 2025

    DOI 10.1016/j.aimed.2025.01.003 Source: ORCID

View all 72 publications